TRIM46: A Potential Drug Target and Biomarker (G80128)

Target Name: TRIM46

NCBI ID: G80128

TRIM46

TRIM46: A Potential Drug Target and Biomarker

TRIM46, short for tripartite motif-containing G protein-coupled receptor 46, is a protein that is expressed in various tissues and cells in the body. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a crucial role in cellular signaling. GPCR is composed of three transmembrane domains: an extracellular domain, a transmembrane domain, and an intracellular domain. The TRIM46 protein has been shown to interact with several other proteins, including the transcription factor p21, the protein kinase kinase A1 (PKA), and the protein tyrosine kinase (PTK).

TRIM46 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the key features of TRIM46 is its tripartite motif, which consists of three parallel beta-sheets that are held together by hydrogen bonds. This motif is unique among GPCR proteins and is indicative of its novelty and potential as a drug target.

In addition to its unique structure, TRIM46 has also been shown to play a crucial role in several cellular processes. For example, TRIM46 has been shown to be involved in cell signaling pathways, including the regulation of cell adhesion, the production of neurotransmitters, and the regulation of cell growth. TRIM46 has also been shown to interact with several other proteins, including the transcription factor p21, the protein kinaseA1 (PKA), and the protein tyrosine kinase (PTK). These interactions suggest that TRIM46 may be involved in the regulation of various cellular processes and could be a potential drug target.

Another potential mechanism by which TRIM46 could be targeted as a drug is its role in the regulation of cellular apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life cycle and is critical for the development and maintenance of multicellular organisms. TRIM46 has been shown to be involved in the regulation of apoptosis, including the inhibition of apoptosis in response to certain stimuli. This suggests that TRIM46 may be a potential drug target for therapies that are designed to promote or inhibit apoptosis.

TRIM46 has also been shown to play a role in the regulation of cellular signaling pathways that are involved in inflammation and pain. For example, TRIM46 has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF- alpha and IL-1. These cytokines are involved in the regulation of cellular signaling pathways that are involved in inflammation and pain. In addition, TRIM46 has also been shown to be involved in the regulation of the production of neuroprotective factors, such as neurotrophins.

In conclusion, TRIM46 is a unique and novel protein that has been shown to play a crucial role in various cellular processes. Its tripartite motif and its unique structure suggest that it may be a potential drug target. Furthermore, its involvement in the regulation of cell signaling pathways and its role in the regulation of cellular apoptosis and inflammation suggest that it may be a useful biomarker for the development of new therapies. Further research is needed to fully understand the role of TRIM46 in cellular processes and to determine its potential as a drug target.

Protein Name: Tripartite Motif Containing 46

Functions: Microtubule-associated protein that is involved in the formation of parallel microtubule bundles linked by cross-bridges in the proximal axon. Required for the uniform orientation and maintenance of the parallel microtubule fascicles, which are important for efficient cargo delivery and trafficking in axons. Thereby also required for proper axon specification, the establishment of neuronal polarity and proper neuronal migration

The "TRIM46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIM46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets